phase readout
saveNCT03850366: HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Henry Ford Health System. Phase: PHASE2. Conditions: Hematological Malignancy
view source ↗
comments(0)
5-min edit window · permanent after that